Winner Medical Co., Ltd. (SHE:300888)
China · Delayed Price · Currency is CNY 29.93
-0.99 (-3.20%)
Oct 27, 2026, 3:04 PM CST
Winner Medical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 11,248 | 10,949 | 8,978 | 8,185 | 11,351 | 8,037 |
Revenue Growth | 4.10% | 21.96% | 9.69% | -27.89% | 41.23% | -35.88% |
Gross Profit Gross Profit Growth | 5,264 | 5,140 | 4,098 | 3,792 | 5,011 | 3,916 |
Operating Income Operating Income Growth | 1,216 | 1,187 | 790.81 | 677.12 | 1,782 | 1,113 |
Net Income Net Income Growth | 776.96 | 767.97 | 695.38 | 580.4 | 1,651 | 1,239 |
Earnings Per Share EPS Growth | 1.34 | 1.32 | 1.19 | 0.98 | 2.79 | 2.08 |
EPS Growth | -10.64% | 10.92% | 21.43% | -64.88% | 34.23% | -70.28% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medical Consumables Medical Consumables Growth | 5,201 | 3,906 | 3,862 | 7,250 | 3,922 |
Consumer Products Consumer Products Growth | 5,749 | 4,991 | 4,263 | 4,008 | 4,054 |
Unallocated Unallocated Growth | - | 81.38 | 60.7 | 93.58 | 61.2 |
Total Total Growth | 10,949 | 8,978 | 8,185 | 11,351 | 8,037 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 5,124 | 4,847 | 4,674 | 7,556 | 9,007 | 7,455 |
Total Debt Total Debt Growth | 3,099 | 2,515 | 2,908 | 2,178 | 2,837 | 597.99 |
Net Cash (Debt) Net Cash Growth | 2,025 | 2,332 | 1,767 | 5,378 | 6,170 | 6,857 |
Net Cash Growth | 85.72% | 32.00% | -67.15% | -12.84% | -10.01% | -15.80% |
Net Cash Per Share Net Cash Per Share Growth | 3.49 | 4.01 | 3.02 | 9.08 | 10.43 | 11.50 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,531 | 1,666 | 1,266 | 1,063 | 2,983 | 871.69 |
Capital Expenditures CapEx Growth | -760.95 | -647.91 | -900.89 | -753.07 | -1,199 | -743.27 |
Free Cash Flow Free Cash Flow Growth | 769.71 | 1,018 | 364.87 | 310.26 | 1,784 | 128.42 |
Free Cash Flow Growth | 2.79% | 178.94% | 17.60% | -82.61% | 1289.26% | -96.94% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 46.80% | 46.95% | 45.65% | 46.33% | 44.15% | 48.73% |
Operating Margin | 10.81% | 10.84% | 8.81% | 8.27% | 15.70% | 13.84% |
Pretax Margin | 9.03% | 9.57% | 10.12% | 9.16% | 16.91% | 18.20% |
Profit Margin | 6.91% | 7.01% | 7.75% | 7.09% | 14.54% | 15.42% |
FCF Margin | 6.84% | 9.29% | 4.06% | 3.79% | 15.72% | 1.60% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.750 | 0.750 | 0.650 | 0.500 | 1.357 | 0.900 |
Dividend Per Share Growth | 14.29% | 15.38% | 30.00% | -63.16% | 50.79% | -50.00% |
Dividend Yield | 2.51% | 1.99% | 1.54% | 1.34% | 2.66% | 1.50% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 22.35 | 28.69 | 35.24 | 37.71 | 18.18 | 28.37 |
Forward PE | 18.25 | 19.21 | 26.38 | 11.53 | 18.04 | 17.13 |
P/FCF Ratio | 22.24 | 21.65 | 67.16 | 70.55 | 16.82 | 273.82 |
PS Ratio | 1.52 | 2.01 | 2.73 | 2.67 | 2.64 | 4.38 |